Loading...
•
Jun 30, 2025
AdaptHealth Q2 2025 Earnings Report
Estimated Revenue:$805M
-0.5% YoY
Estimated EPS:$0.16
16.2% YoY
Key Takeaways
AdaptHealth delivered solid results in the second quarter of 2025, with net revenue of $800.4 million. While net revenue and adjusted EBITDA saw slight decreases year-over-year, the company highlighted progress in driving revenue growth through new partnerships, improving operating efficiency, and reducing debt.
Net revenue for Q2 2025 was $800.4 million, a 0.7% decrease from Q2 2024.
Adjusted EBITDA for Q2 2025 was $155.5 million, a 5.9% decrease from Q2 2024.
Net income attributable to AdaptHealth Corp. was $14.7 million in Q2 2025.
The company is advancing initiatives to boost operating efficiency, elevate patient experience, and expand profit margins.
Forward Guidance
AdaptHealth updated its financial guidance for fiscal year 2025, adjusting net revenue and adjusted EBITDA ranges while maintaining its free cash flow outlook.
Positive Outlook
- New capitated partnership with a major national healthcare system expected to drive revenue growth.
- Advancing multiple initiatives to boost operating efficiency and expand profit margins.
- Making rapid progress reducing debt and fortifying financial position.
- Fiscal year 2025 free cash flow guidance remains unchanged at $170 million to $190 million.
- Continued dedication to providing exceptional service to 4.2 million patients.
Challenges Ahead
- Updated fiscal year 2025 net revenue guidance range slightly lower at the high end ($3.18 billion to $3.26 billion from $3.15 billion to $3.29 billion).
- Updated fiscal year 2025 adjusted EBITDA guidance range lower ($642 million to $682 million from $662 million to $702 million).
- No specific negative operational outlooks were provided beyond the adjusted guidance.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...